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ABSTRACT
Time-to-positivity is useful in the diagnosis of catheter-related bacteraemia and as a predictor of an
endovascular source in patients with Staphylococcus aureus bacteraemia. However, this parameter has
been evaluated for only a limited number of microorganisms. In the present study, time-to-positivity
was recorded for 1872 episodes of signiﬁcant monomicrobial bacteraemia diagnosed at a teaching
hospital during a 2-year period, and the associated microbial and clinical variables were investigated.
According to multivariate analysis, Streptococcus pneumoniae, b-haemolytic streptococci, Escherichia coli,
Klebsiella, Enterobacter, Citrobacter and Aeromonas were characterised by fast growth, with an endovas-
cular source, shock, liver cirrhosis and neutropenia also predicting a short time-to-positivity. For
patients not receiving appropriate antibiotics, detection of Gram-positive cocci in clusters within 14 h
was predictive of Staph. aureus; a time-to-positivity of >21 h ruled out the possibility that a Gram-
positive organism in chains was a b-haemolytic streptococcus or Strep. pneumoniae, and a time-to-
positivity of £12 h meant that it was very unlikely that a Gram-negative bacillus was a non-fermenter.
A time-to-positivity of £8 h was predictive of a non-urinary tract source in patients with E. coli
bacteraemia, and detection of growth within 13 h predicted an endovascular source in those with
Staph. aureus bacteraemia. In conclusion, time-to-positivity depended on the microorganism, original
source and clinical variables involved. Although this measurement may provide some early clues
concerning the microorganisms involved and the source of bacteraemia, its clinical impact remains to be
deﬁned.
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INTRODUCTION
Time-to-positivity for a given microorganism, as
assessed by automated blood culture processing
devices, depends on the bacterial inoculum [1],
which may in turn be inﬂuenced by the source of
infection, the presence of antimicrobial agents [2]
and the patient’s clinical characteristics. Differen-
tial time to detection of growth has proven to be
useful in the diagnosis of intravenous catheter-
related bacteraemia [3–5]. In addition, there is
evidence that the magnitude of bacteraemia in
patients with Staphylococcus aureus bloodstream
infection, as indicated by a short time-to-positiv-
ity, independently predicts an endovascular
source of infection, the duration of bacteraemia,
metastatic infection and the attributable mortality
[6,7]. A short time-to-positivity has also been
reported to be an independent predictor of fatal
outcome in patients with diverse-source Escheri-
chia coli bacteraemia [8], and to be a marker of
severe sepsis or shock and meningitis in individ-
uals with bloodstream infection caused by Strep-
tococcus pneumoniae [9]. It is also well-known that,
with a similar inoculum, the speed of growth in
culture media differs according to the bacterial
species. Hence, knowledge of the time-to-positivity
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when inspecting a Gram’s stain of a smear from a
blood culture bottle may have some value in
forecasting the species or family to which a
microorganism belongs [10].
Until now, time-to-positivity and the variables
associated with it have been evaluated with only a
limited number of bacterial species. The present
study investigated the time-to-positivity values
for species causing signiﬁcant bacteraemia at a
university hospital during a 2-year period. Mul-
tivariate analysis methods were used to ascertain
the microbiological and clinical variables associ-
ated with the rapidity of growth detection, and
the potential usefulness of time-to-positivity in
predicting the involvement of selected organisms
or sources of bacteraemia was explored.
PATIENTS AND METHODS
Patients
During a 2-year period (January 2002 to December 2003), time-
to-positivity was recorded for all positive blood cultures
obtained at Hospital Clı´nic, a 700-bed university hospital in
Barcelona, Spain. The present study focused on episodes of
monomicrobial bacteraemia that were considered to be clinic-
ally signiﬁcant. An episode of bacteraemia was deﬁned as any
de-novo bloodstream infection, or an episode that occurred
after the apparent clinical cure and source eradication in
patients with a previous history of bacteraemia. For an episode
of bacteraemia to be considered as clinically signiﬁcant, previ-
ous criteria [11] were modiﬁed as follows: (i) certain microor-
ganisms, e.g., Staph. aureus, Strep. pneumoniae, b-haemolytic
streptococci or any Gram-negative organism, isolated from
one or more blood cultures, always represented a true bacter-
aemia; (ii) for viridans group streptococci and enterococci, at
least one positive blood culture and clinical signs of infection
were required; and (iii) common skin contaminants (coagulase-
negative staphylococci, diphteroids, Bacillus spp.) had to be
isolated from at least two blood cultures in the presence of fever
(body temperature >38C), rigors or hypotension (systolic
blood pressure <90 mmHg). In addition, organisms isolated
from two blood cultures required an identical susceptibility
pattern in order to be classed as signiﬁcant bacteraemia.
Clinical variables
Clinical variables recorded for patients with bacteraemia
included: demographics (age and gender); place of acquisition
(hospital or community); primary source of infection; under-
lying diseases; McCabe classiﬁcation of underlying diseases
[12]; neutropenia; selected clinical aspects (metastatic infection,
shock); and current treatment with corticosteroids and sys-
temic antibiotics with in-vitro activity against the microorgan-
ism involved (appropriate antimicrobial therapy) when the
blood for culture was drawn.
The source of infection was established according to
common clinical, analytical and radiographical criteria. All
patients with potentially signiﬁcant bacteraemia were seen by
an infectious disease specialist, who made the ﬁnal decision
concerning the source after reviewing the available clinical and
microbiological information. In order for a venous catheter to
be considered as the source of infection, a positive culture of
the catheter tip by the roll-plate method, a differential time-to-
positivity between a peripheral and a catheter blood sample of
at least 2 h, or the presence of local inﬂammatory signs with no
evidence of another putative origin was required. Endocarditis
was diagnosed using the modiﬁed Duke criteria [13].
Microbiological procedures
Blood cultures were processed using the Bactec 9240 system
(Becton-Dickinson, Sparks, MD, USA). When using media
without resins, the standard aerobic bottle (Bactec Standard ⁄ 10
Aerobic ⁄ F) was always paired with the Bactec Lytic ⁄ 10
Anaerobic ⁄F bottle. Aerobic and anaerobic resin bottles were
Bactec Plus Aerobic ⁄ F and Bactec Plus Anaerobic ⁄ F, respect-
ively. The current protocol recommends ﬁlling each bottle with
8 mL of blood, but the actual volume of blood cultured was
not recorded in the present study. The time from the start of
incubation to a positive reading was monitored, with time-to-
positivity being recorded when the ﬁrst bottle became positive
in each set or sets processed. For patients from whom
simultaneous positive catheter and peripheral cultures were
available, the sample with the shortest time-to-positivity was
analysed, while only the initial cultures were assessed for
patients with persistent bacteraemia. Standard bacteriological
techniques were used for the identiﬁcation of microorganisms.
Antibiotic susceptibilities and production of extended-spec-
trum b-lactamase were determined according to CLSI guide-
lines [14]. Episodes of polymicrobial bacteraemia, fungaemia
and mycobacteraemia were excluded.
Statistical analysis
Time-to-positivity was expressed as the median (inter-quartile
interval). Pairwise comparisons of time-to-positivity among
different microorganims were performed using the Kruskal–
Wallis test, with correction for multiple comparisons when
appropriate. A Cox proportional-hazards regression model
was used for both univariate and multivariate analysis to
assess the association of time-to-positivity with clinical and
microbiological variables in the entire series of bacteraemic
episodes.
In multivariate analysis, indicator variables were created
for both ‘microorganism’ and ‘source of infection’, taking
‘methicillin-susceptible Staph. aureus’ (MSSA) and an ‘un-
known source’ as the comparison groups, respectively. MSSA
was chosen as the reference group because it was the largest
microbial category, with a time-to-positivity distribution close
to that of the entire study sample. The complete set of available
co-variates was subjected to selection by a stepwise forward
procedure. For the purpose of interpretation, a hazard ratio of
<1 demonstrated a higher time-to-positivity for episodes with
the co-variate compared to episodes without the co-variate,
and the converse applied to hazard rate values >1.
To assess the potential role of time-to-positivity in predict-
ing the involvement of selected microorganisms or the source
of bacteraemia in episodes caused by speciﬁc microorganisms,
receiver operator curves were constructed by plotting the rate
of true-positive results (sensitivity) against the rate of false-
positive results (1 ) speciﬁcity), which allowed the selection of
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cut-off values with the best balance between sensitivity and
speciﬁcity. The relevance of these cut-off values in predicting
the source of bacteraemia was investigated by introducing the
corresponding variable in logistic regression models along
with other potential confounders (age, gender, underlying
diseases, McCabe classiﬁcation, neutropenia, corticosteroid
therapy, bladder catheter, shock on clinical presentation and
appropriate antimicrobial therapy). The assessment of time-to-
positivity as a predictor of the source of bacteraemia was
limited to bacterial species for which the source of potential
clinical interest and the other sources were each represented in
at least 40 episodes.
RESULTS
Cases of bacteraemia
During the study period, there were 1872 epi-
sodes of signiﬁcant monomicrobial bacteraemia.
Simultaneous positive catheter and peripheral
samples were available for 117 (6%) episodes,
catheter samples only for 274 (15%) episodes, and
peripheral samples only for 1481 (79%) episodes.
Methicillin-resistant Staph. aureus (MRSA) and
MSSA were considered separately because their
time-to-positivity values were signiﬁcantly differ-
ent (median 14.5 h, range 9.14–17.54 vs. 11.7 h,
range 8.3–14.5 h, respectively; p 0.02). Conver-
sely, no differences were observed between exten-
ded-spectrum b-lactamase-producing Esch. coli or
Klebsiella spp. and their non-extended-spectrum
b-lactamase-producing counterparts, or between
Proteus mirabilis and other Proteeae; hence, each of
these combinations was considered as a single
species. For the same reason, catheter-related
bacteraemia and other endovascular sources were
pooled together as a group.
Microbial and clinical determinants of
time-to-positivity
The frequencies of the clinical and microbiological
characteristics, together with their associated
time-to-positivity and corresponding unadjusted
hazard ratios (univariate analysis), are shown in
Tables 1 and 2, respectively. Among the
Gram-positive bacteria, Strep. pneumoniae and
b-haemolytic streptococci had the shortest time-
to-positivity values (median <11 h). Among
Gram-negative microorganisms, E. coli, Klebsiella
spp., Citrobacter spp., Enterobacter spp. and Aero-
monas spp. had median times-to-positivity of
<10 h, whereas Pseudomonas aeruginosa, other
non-fermenters, other Gram-negative bacteria
and anaerobes had the longest times (median
>15 h).
With respect to the source of infection, the
shortest time-to-positivity was observed for
episodes originating from the biliary and urinary
tracts. Conversely, an unknown source was
associated with a signiﬁcantly longer time-to-
positivity. A longer time-to-positivity was also
observed for nosocomial episodes, and for
episodes occurring in patients who were being
treated with corticosteroids and appropriate
antibiotics, whereas renal insufﬁciency and liver
cirrhosis were associated with a signiﬁcantly
shorter time-to-positivity.
Multivariate analysis selected certain microor-
ganisms, clinical characteristics and sources as
being associated independently with time-to-
positivity (Table 3). Strep. pneumoniae, b-haemolytic
streptococci, E. coli, Klebsiella spp., Enterobacter
spp., Citrobacter spp. and Aeromonas spp. were
characterised by fast growth, whereas coagulase-
negative staphylococci (CoNS), Listeria monocyto-
genes, P. aeruginosa, other non-fermenters, other
Gram-negative bacteria and anaerobes were asso-
ciated with a longer period before growth was
detected. After adjusting for the microorganism
and clinical variables, an endovascular source
was associated independently with short time-to-
positivity, while the urinary tract and the lung
were associated with a longer time-to-positivity.
Among the clinical factors investigated, shock,
liver cirrhosis and neutropenia predicted faster
growth, whereas corticosteroid therapy and
current appropriate antimicrobial treatment
remained associated with an increased time-to-
positivity.
Time-to-positivity as a predictor of selected
microorganisms
Signiﬁcant differences existed in the distribution of
time-to-positivity values among species or groups
of microorganisms sharing a similar morphology
following Gram’s stain. Among Gram-positive
cocci, time-to-positivity was signiﬁcantly shorter
for bothMSSA andMRSA than for CoNS (p <0.05).
b-Haemolytic streptococci had a signiﬁcantly
shorter time-to-positivity than any of the other
streptococci, and Strep. pneumoniae grew signiﬁ-
cantly faster than enterococci and viridans
group streptococci (p <0.05 for all comparisons).
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However, there was no difference in time-to-
positivity between the latter two groups of organ-
isms. Among Gram-negative bacilli (excluding
anaerobes and species of the miscellaneous group
shown in Table 2), time-to-positivity did not differ
signiﬁcantly among E. coli, Klebsiella spp., Entero-
bacter spp., Citrobacter spp. and Aeromonas spp.
on the one hand, or among Proteeae, Salmonella
spp., Serratia spp., P. aeruginosa and other non-
fermenters on the other. However, the time-to-
positivity of each member of the former group of
Gram-negative bacilli was signiﬁcantly shorter
than that of each of the latter group (p <0.05 for
all comparisons). The results were identical,
whether all episodes of bacteraemia or only those
that were not treated with appropriate antibiotics
were considered.
Performance characteristics of time-to-positivity
as a diagnostic test for (i) Staph. aureus vs. CoNS,
(ii) for b-haemolytic streptococci or Strep. pneumo-
niae vs. enterococci or viridans group streptococci,
and (iii) for Enterobacteriaceae or Aeromonas
spp. vs. non-fermenters in episodes without
appropriate antimicrobial therapy are shown in
Table 4. A cut-off value that virtually conﬁrmed or
excluded the diagnosis was not found for
Staph. aureus and Gram-negative bacilli, albeit
positive predictive values high enough to be of
potential clinical meaning could be deﬁned. All
strains of b-haemolytic streptococci or Strep. pneu-
moniae grew in £21 h; thus, the involvement of
these species in blood cultures with Gram-positive
cocci in chains that become positive after that
length of time can be ruled out.
Time-to-positivity as a predictor of selected
sources of bacteraemia for the most common
microorganisms
Of 223 bacteraemic episodes caused by Staph.
aureus, 200 (90%) involved patients who were not
receiving appropriate antimicrobial therapy, and
an endovascular source was identiﬁed in 106
(48%) and 88 (44%) cases, respectively. An
Table 1. Distribution of clinical characteristics according to the corresponding time-to-positivity and unadjusted hazard
ratios for 1872 episodes of bacteraemia
Characteristic No. (%)
Time-to-positivitya
Hazard ratio
(95% CI)Characteristic present Characteristic absent
Age >65 yearsb 994 (53) 11.1 (8.8–16) 11.8 (8.8–17) 1.05 (0.96–1.15)
Male gender 1047 (56) 11.7 (8.8–16.3) 11.2 (8.8–16.8) 1 (0.9–1.1)
Liver cirrhosis 177 (9) 10.8 (8.7–15.4) 11.6 (8.8–16.7) 1.17 (1–1.37)
Diabetes 378 (20) 11.7 (9–17) 11.5 (8.7–16.3) 0.97 (0.86–1.08)
COPD 141 (8) 12 (9.2–17) 11.4 (8.7–16.5) 0.94 (0.79–1.11)
HIV 95 (5) 11.3 (8.6–15.6) 11.5 (8.8–16.6) 0.96 (0.8–1.18)
Renal insufﬁciency 186 (10) 10.7 (8.3–15.4) 11.6 (8.8–16.7) 1.19 (1.02–1.38)
Heart failure 264 (14) 11.9 (8.8–16) 11.5 (8.8–16.6) 1.03 (0.9–1.17)
Haematological cancer 221 (12) 12.1 (8.9–18) 11.4 (8.8–16.1) 0.9 (0.8–1.04)
HSCT 31 (2) 13.9 (9–22) 11.5 (8.8–16.4) 0.77 (0.54–1.1)
Solid cancer 343 (18) 11.6 (8.7–16.7) 11.5 (8.8–16.4) 1 (0.89–1.12)
Solid organ transplantation 128 (7) 11.44 (8.4–15.4) 11.5 (8.8–16.6) 1.08 (0.9–1.27)
Neutropenia 134 (7) 11.7 (9–17) 11.5 (8.8–16.3) 1 (0.84–1.2)
Other underlying diseases 304 (16) 11.8 (8.8–17.4) 11.5 (8.8–16.2) 0.86 (0.76–0.97)
McCabe classiﬁcationc 881 (47) 11.7 (8.8–17) 11.3 (8.7–16) 0.96 (0.87–1.05)
Hospital-acquired infection 764 (41) 12.7 (9–18) 10.8 (8.6–15) 0.81 (0.73–0.88)
Corticosteroids 371 (20) 12.7 (8.9–18.7) 11.2 (8.8–16) 0.83 (0.74–0.93)
Septic metastasis 29 (2) 11.1 (8.3–15) 11.5 (8.8–16.5) 1.14 (0.79–1.64)
Appropriate antibiotics 118 (6) 12.9 (9.7–21.2) 11.3 (8.8–16.3) 0.75 (0.62–0.9)
Shock 241 (13) 11 (8.1–15.8) 11.6 (8.8–16.6) 1.04 (0.9–1.2)
Pneumonia 172 (9) 11.8 (10.3–15.4) 11.4 (8.7–16.7) 0.93 (0.8–1.1)
Skin and soft-tissue source 109 (6) 11.8 (8.8–17.3) 11.5 (8.8–16.5) 1.05 (0.86–1.27)
Urinary tract source 388 (21) 10 (8.6–12.6) 12 (8.9–17.2) 1.29 (1.15–1.44)
Endovascular sourced 403 (22) 12.7 (8.6–17.6) 11.2 (8.8–16.1) 0.92 (0.82–1.03)
Intra-abdominal source 103 (6) 10.6 (8.6–18) 11.5 (8.8–16.4) 1 (0.81–1.21)
Biliary tract source 132 (7) 9.6 (7.5–12.9) 11.6 (8.8–16.8) 1.4 (1.17–1.67)
Unknown source 491 (26) 13 (9.2–17.7) 11.1 (8.6–15.6) 0.85 (0.77–0.95)
Other sourcese 74 (4) 12.8 (9.2–20.8) 11.5 (8.8–16.3) 0.78 (0.62–0.99)
Characteristics with statistical signiﬁcance are printed in bold.
aData are expressed as the median in hours (inter-quartile interval).
bMean age: 63.56 ± 17.9 years.
cUltimately ⁄ﬁnally fatal underlying disease.
dIncludes 355 catheter-related infections and 48 other endovascular sources (40 endocarditis, two infected aortic aneurysms, one native arterio-venous ﬁstula for
haemodialysis, two vascular prosthesis infections and three pacemaker infections).
eIncludes 23 acute gastroenteritis, 20 meningitis, 15 osteoarticular infections, nine invasive procedures, four psoas abscesses, one malignant external otitis, one peri-rectal
abscess and one mediastinitis.
COPD, chronic obstructive pulmonary disease; HIV, human immunodeﬁciency virus; HSCT, haematopoietic stem-cell transplantation.
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intravenous catheter was involved in 94 (87%)
endovascular episodes in the entire series of
patients with Staph. aureus bacteraemia, and in
81 (92%) of those patients who were not receiving
appropriate antibiotics. Regardless of the use of
appropriate antimicrobial therapy, a time-to-pos-
itivity cut-off value of £13 h showed the best
balance between sensitivity and speciﬁcity for the
diagnosis of an endovascular source (sensitivity
68%, speciﬁcity 55%). After adjusting for poten-
tial confounders, a time-to-positivity of £13 h
remained signiﬁcantly associated with an endo-
vascular source of infection in the entire series
(OR 2.6, 95% CI 1.4–4.8) and in the episodes
without appropriate antibiotics (OR 2.5,
95% CI 1.3–4.8). For patients who did not receive
appropriate antibiotics, a nosocomial origin of
infection (OR 3.7, 95% CI 1.8–7.3), chronic renal
failure (OR 5, 95% CI 2–12), an age <65 years
(OR 2.8, 95% CI 1.4–5.7), heart failure (OR 2.9,
95% CI 1.2–7) and the absence of shock (OR 8.3,
95% CI 1.9–37) were also revealed as indepen-
dent predictors. In the entire series, appropriate
antimicrobial therapy was added to the above-
mentioned variables as a signiﬁcant predictor of
an endovascular source (OR 4.8, 95% CI 1.5–15).
Of 304 bacteraemic episodes caused by CoNS,
274 (90%) occurred in patients who did not
receive appropriate antibiotics, and an endovas-
cular source was identiﬁed in 146 (48%) and 123
(45%) cases, respectively. An intravenous catheter
was involved in 137 (94%) endovascular episodes
in the entire series, and in 114 (93%) patients who
did not receive appropriate antibiotics. Regardless
of treatment with antibiotics, most (83–84%) epi-
sodes unrelated to an endovascular source were
deﬁned as being of unknown origin, and the
Table 2. Distribution of aetiological microorganisms with their corresponding time-to-positivity and unadjusted hazard
ratios for 1872 episodes of bacteraemia
Microorganisms No. (%)
Time-to-positivitya
Hazard ratio
(95% CI)Characteristic present Characteristic absent
MSSA 175 (9) 11.7 (8.3–14.5) 11.5 (8.8–16.7) 1.13 (0.96–1.32)
MRSA 48 (3) 14.5 (9.1–17.5) 11.4 (8.8–16.5) 0.83 (0.62–1.1)
CoNS 304 (16) 17.3 (13.9–20.9) 10.7 (8.6–14.4) 0.58 (0.52–0.66)
Streptococcus pneumoniae 96 (5) 10.9 (9.2–11.7) 11.7 (8.8–16.9) 1.83 (1.48–2.25)
Viridans group streptococci 51 (3) 11.8 (9.7–15.3) 11.6 (8.8–16.7) 1.1 (0.83–1.46)
b-Haemolytic streptococci 44 (2) 8.75 (7.6–9.8) 11.6 (8.9–16.7) 3.04 (2.24–4.11)
Enterococci 100 (5) 13 (10.5–16.5) 11.3 (8.7–16.5) 0.92 (0.75–1.13)
Listeria monocytogenes 26 (1) 18.14 (14.7–22.3) 11.4 (8.8–16.2) 0.56 (0.38–0.83)
Escherichia coli 532 (28) 9.3 (8–11.4) 12.9 (9.6–17.8) 1.84 (1.66–2)
Klebsiella spp. 122 (7) 9.25 (7.5–11.4) 11.7 (8.9–16.8) 1.54 (1.28–1.86)
Proteeae 41 (2) 11.4 (9.9–14.2) 11.5 (8.8–16.6) 0.98 (0.72–1.34)
Enterobacter spp. 42 (2) 9.8 (7.4–11.8) 11.5 (8.8–16.7) 1.64 (1.21–2.24)
Citrobacter spp. 12 (0.6) 8.5 (5.3–9.9) 11.5 (8.8–16.6) 3.51 (1.98–6.2)
Salmonella spp. 36 (2) 12.5 (10.6–20.4) 11.5 (8.8–16.5) 0.8 (0.57–1.11)
Serratia spp. 16 (0.8) 13.1 (10.6–17.9) 11.5 (8.8–16.5) 0.69 (0.42–1.13)
Aeromonas spp. 10 (0.5) 7.59 (6.4–9) 11.69 (8.9–16.8) 4.24 (2.28–7.89)
Pseudomonas aeruginosa 124 (7) 15.25 (11.6–17.8) 11.3 (8.7–16.1) 0.71 (0.59–0.86)
Other non-fermentersb 37 (2) 19.6 (11.8–33.2) 11.4 (8.8–16.2) 0.54 (0.38–0.74)
Anaerobes 35 (2) 26 (20.3–29.7) 11.4 (8.8–16.1) 0.41 (0.29–0.57)
Other Gram-negative bacteriac 17 (0.9) 23.79 (13.4–63.3) 11.5 (8.8–16.4) 0.37 (0.22–0.6)
Characteristics with statistical signiﬁcance are printed in bold.
aData are expressed as the median in hours (inter-quartile interval).
bIncludes 15 Acinetobacter baumannii, 12 Stenotrophomonas maltophilia, ﬁve Pseudomonas spp., three Alcaligenes spp., one Flavimonas oryzihabitans and one Ochrobactrum anthropi.
cIncludes three Neisseria meningitidis, four Haemophilus spp., ﬁve Campylobacter spp., two Pasteurella multocida, one Capnocytophaga ochracea, one Hafnia alvei and one Yersinia
enterocolitica.
MSSA, methicillin-susceptible Staphylococcus aureus; MRSA, methicillin-resistant Staphylococcus aureus; CoNS, coagulase-negative staphylococci.
Table 3. Variables selected by the multivariate Cox pro-
portional-hazards model as being associated independ-
ently with time-to-positivity
Characteristic Hazard ratio (95% CI)
Pneumonia 0.75 (0.62–0.91)
Urinary tract infection 0.78 (0.67–0.9)
Endovascular infection 1.33 (1.16–1.52)
Liver cirrhosis 1.24 (1.05–1.45)
Neutropenia 1.28 (1.07–1.55)
Shock 1.19 (1.03–1.37)
Corticosteroids 0.86 (0.76–0.97)
Appropriate antibiotics 0.79 (0.65–0.96)
CoNS 0.57 (0.49–0.67)
Streptococcus pneumoniae 2.47 (1.91–3.21)
b-Haemolytic streptococci 3.46 (2.52–4.74)
Listeria monocytogenes 0.54 (0.36–0.81)
Escherichia coli 1.98 (1.71–2.29)
Klebsiella spp. 1.79 (1.45–2.21)
Enterobacter spp. 1.82 (1.32–2.5)
Citrobacter spp. 4.74 (2.66–8.45)
Aeromonas spp. 4.38 (2.32–8.24)
Pseudomonas aeruginosa 0.76 (0.62–0.93)
Other non-fermenters 0.5 (0.36–0.71)
Other Gram-negative bacteria 0.38 (0.23–0.62)
Anaerobes 0.49 (0.27–0.56)
CoNS, coagulase-negative staphylococci.
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majority (62–63%) of these occurred in patients
with a venous catheter in place. Time-to-positivity
was not predictive of an endovascular source, as
the receiver operator curve was a straight line
running close to the diagonal of the sensitivity vs.
(1 ) speciﬁcity) plot (results not shown).
Based on the total number of episodes, multiva-
riate analysis identiﬁed a nosocomial origin of
infection (OR 4.6, 95% CI 2.6–7.8), renal insufﬁ-
ciency (OR 3.4, 95% CI 1.5–7.9), treatment with
appropriate antimicrobial agents (OR 3.1, 95%
CI 1.2–7.9) and neutropenia (OR 3.3, 95% CI
1.4–8.1) as the best predictors of an endovascular
source. After adjusting for these variables, a time-
to-positivity of £12 h showed a trend towards
statistical signiﬁcance (OR 1.7, 95% CI 0.9–3.3;
p 0.09).
Virtually all episodes (520 of 532; 98%) of
bacteraemia caused by E. coli were not associated
with appropriate antimicrobial therapy, and 289
(56%) originated from the urinary tract. The
ability of time-to-positivity to predict a non-
urinary source was only moderate, with £8 h
being the best cut-off value (sensitivity 34%,
speciﬁcity 80%). Logistic regression analysis
identiﬁed a time-to-positivity of £8 h (OR 1.7,
95% CI 1.1–2.7), a nosocomial origin of infection
(OR 5.4, 95% CI 2.9–10), male gender (OR 2.3,
95% CI 1.5–3.4), an ultimately or rapidly fatal
underlying disease (OR 2.5, 95% CI 1.7–3.8),
shock (OR 2.5, 95% CI 1.3–4.8), absence of a
bladder catheter (OR 5, 95% CI 2.4–10.6) and
absence of diabetes mellitus (OR 2.3,
95% CI 1.3–3.9) as the best predictors of a non-
urinary tract source.
DISCUSSION
The present study revealed that selected micro-
organisms, sources of infection and clinical
conditions are independently associated with
the time at which growth is detected. However,
the meaning of these associations differs,
depending on whether the variables are micro-
biological (microorganisms) or clinical. Faster or
slower growth of some species is probably
indicative of intrinsic differences in doubling
time, whereas the association with clinical vari-
ables after adjusting for the microorganism
probably reﬂects differences in the inoculum
originally present in the blood.
The distinct distribution of time-to-positivity
among species may help to make predictions,
once the Gram’s stain result for the content of a
positive blood culture bottle is available, concern-
ing the particular organism or class of organisms
involved [10]. According to the present data, the
positive predictive value of a time-to-positivity of
£14 h for the presence of Staph. aureus in patients
not taking antibiotics who had blood cultures
with Gram-positive cocci in chains reached 65%,
which may suggest immediate additional thera-
peutic measures in such circumstances, e.g.,
withdrawal of a venous catheter. Similar predic-
tive values (77% when growth was detected in
<14 h) have been reported in a previous study
[10]. In contrast, a time-to-positivity of >21 h
ruled out the possibility that a Gram-positive
organism in chains was a b-haemolytic strepto-
coccus or Strep. pneumoniae. For Gram-negative
bacilli, a time-to-positivity of £12 h suggested that
Table 4. Performance characteristics of time-to-positivity for the main groups of microorganisms at the cut-off values
deﬁning the best balance between sensitivity and speciﬁcity, test sensitivity and best speciﬁcity
Microorganisms Cut-off Sensitivity Speciﬁcity Positive predictive value Negative predictive value
Staphylococcus aureus vs. CoNS
Best balance: sensitivity ⁄ speciﬁcity £14 h 65.5 (58.4–72) 73.7 (68.1–78.8) 64.5 (57.5–71.1) 74.5 (68.9–79.6)
Best sensitivity £23 h 91.5 (86.7–94.9) 14.2 (10.3–18.9) 43.7 (38.9–48.6) 69.6 (55.9–81.2)
Best speciﬁcity £7 h 12 (7.8–17.3) 95.2 (92–97.4) 64.8 (47.4–78.8) 59.7 (54.9–64.3)
b-Haemolytic streptococci or
Streptococcus pneumoniae
vs. other streptococci
Best balance: sensitivity ⁄ speciﬁcity £11 h 67.6 (59.1–75.3) 71.2 (62.9–78.5) 70.1 (61.5–77.7) 68.7 (60.5–76)
Best sensitivity £21 h 100 (97.3–100) 10 (5.6–16.3) 52.7 (46.4–58.8) 100 (78.1–100)
Best speciﬁcity £6 h 7.9 (4–13.7) 97.8 (93.8–99.5) 78.5 (49.2–95.3) 51.5 (45.3–57.6)
Enterobacteriaceae or
Aeromonas spp.
vs. non-fermenters
Best balance: sensitivity ⁄ speciﬁcity £12 h 77.5 (74.4–80.4) 72.1 (63.9–79.4) 94 (91.8–95.7) 36.5 (30.7–42.4)
Best sensitivity £25 h 94.3 (92.5–95.8) 17.8 (11.9–25.2) 86.5 (84–88.7) 36 (24.6–48)
Best speciﬁcity £6 h 9.6 (7.6–11.8) 98.6 (94.9–99.8) 97.4 (91–99.6) 16.3 (13.8–18.9)
Sensitivity, speciﬁcity and predictive values are expressed as percentages (95% CI).
CoNS, coagulase-negative staphylococci.
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the involvement of a non-fermenting organism
was very unlikely (c. 6%), whereas this likelihood
increased to 37% in other situations.
The present study also demonstrated that it is
not meaningful to make predictions concerning
the source of bacteraemia, based on time-to-
positivity, without taking into account the
microorganism involved. In univariate analysis,
time-to-positivity in episodes with an endovas-
cular source did not differ signiﬁcantly from that
of episodes with other sources, whereas urinary
tract infections were associated with a shorter
time-to-positivity. However, multivariate analy-
sis revealed that this observation was entirely
caused by the fact that endovascular infections
frequently involved organisms with a relatively
slow growth rate, while faster-growing species
were usually involved in urinary tract infections.
The present data suggest that, regardless of the
microorganism involved, endovascular infections
are associated with a higher degree of bacterae-
mia than infections involving other sources,
whereas urinary tract infections and pneumonia
are associated with a lower blood inoculum.
With respect to the possible use of time-to-
positivity to predict the source of bacteraemia
once the microbial species is known, the results
conﬁrmed previous data indicating that a time-to-
positivity of £14 h is an independent predictor of
endovascular infection in patients with bacterae-
mia caused by Staph. aureus [6]. Other important
risk-factors selected by multivariate analysis
(nosocomial acquisition and chronic renal failure)
were not unexpected, considering that most of
these infections were catheter-related. It should be
noted that detection of Staph. aureus in blood
while the patient was receiving appropriate anti-
microbial therapy was also an independent pre-
dictor of endovascular infection. This ﬁnding
agrees with previous observations linking an
endovascular source with the presence of break-
through or persistent bacteraemia [15,16]. It was
not possible to deﬁne a cut-off value predictive
of an endovascular source for CoNS, perhaps
because many infections labelled as ‘unknown
source’ in patients with a venous catheter in place
were actually catheter-related. A time-to-positiv-
ity value of £8 h was an independent predictor of
a non-urinary tract source in patients with bac-
teraemia caused by E. coli. For other organisms
and sources, the sample sizes were probably too
low for accurate predictions to be made.
Present data suggest that some clinical condi-
tions, e.g., liver cirrhosis and neutropenia, are
associated with a higher degree of bacteraemia,
independent of other factors. This may be related
to the deﬁciency in phagocytic functions associ-
ated with such diseases [17]. On the other hand, it
is surprising that administration of corticosteroids
seemed to be linked to a lower degree of bacter-
aemia, despite the expected detrimental activity
of these drugs on phagocytes. However, it has
been recognised that corticosteroids increase the
number and lifespan of polymorphonuclear leu-
kocytes in peripheral blood without diminishing
the microbiocidal activity of these cells, which
could contribute to a reduction in the circulating
bacterial load [18,19]. Although this explanation is
speculative, the possibility that corticosteroids
may reduce the degree of bacteraemia is interest-
ing and deserves further investigation. Finally,
neither the positive association of a surrogate
marker of the degree of bacteraemia with shock,
nor its negative relationship with appropriate
antimicrobial therapy, is an unexpected ﬁnding.
Severe sepsis or shock has been associated with a
short time-to-positivity in patients with blood-
stream infections caused by Strep. pneumoniae [9],
and a direct correlation of time-to-positivity with
antimicrobial activity in serum, in both in-vitro
and ex-vivo experiments, has been noted previ-
ously [2]. Present data conﬁrm previous observa-
tions indicating that time-to-positivity is longer
for MRSA than for MSSA [6], but the fact that this
difference did not persist in the multivariate
model suggests that it is confounded by factors
related to the source or other clinical variables,
rather than relying on distinct growth rates of
these microorganisms.
In contrast to studies reported previously, a
shorter time-to-positivity was observed for both
Staph. aureus and CoNS [6,10], even though one of
these studies used the same processing device
[10]. Some of these differences can be attributed to
singularities of the population studied, but other
factors that are usually not quantiﬁed or men-
tioned, e.g., the actual volume of blood used to
inoculate the bottles, the kind of bottles used, the
use of resin vials, the prevalence of exclusive
catheter samples, or current appropriate antimi-
crobial therapy, may also inﬂuence the results.
However, this variability seems to have a
relatively small inﬂuence on the cut-off values
proposed for diagnostic purposes.
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The present study has several caveats. The
most obvious are that the volume of blood
cultured and the time that elapsed between
taking the blood and loading it into the process-
ing device were not recorded, in the assumption
that variations occurred randomly. In a similar
manner, any assumption about blood inoculum
derived from time-to-positivity presumes that
the growth rate distribution for different strains
of a given microorganism is analogous for
different sources or clinical conditions. Given
these shortcomings, and the fact that statistical
differences are very small for many situations
(microorganism or clinical source), it remains
unclear whether the results of this study will
have a clinical impact on individual patients.
Nevertheless, time-to-positivity may provide
early clues about the microorganisms involved
and the source of bacteraemia. Although further
studies are required, the present data also
suggest that the blood inoculum is relatively
high in episodes of bacteraemia associated with
shock, liver cirrhosis or neutropenia, or origin-
ating from an endovascular source, and low in
those associated with the urinary tract or lung.
In addition to antibiotics, corticosteroids may
also be associated with a lower magnitude of
bacteraemia.
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